Clinical trial
Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes
NCT02316483 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- December 31, 2019
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
charcot arthropathy, type 2 diabetes